Scientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology in Jupiter have received $15.7 million in four separate federal grants to help with their research over ...

A pharmacy company in Philadelphia pleaded guilty Wednesday to felony Medicaid and Medicare fraud and theft charges involving reimbursements for unregulated HIV medications and is paying more than $2 ...

Uganda is set to introduce a new long-acting HIV prevention drug, Lenacapavir, in 2026 under a United States–funded initiative, offering fresh hope in the fight against the epidemic. The twice-yearly ...

It’s super effective after about 7 days of consistent use …”  “Have there been people who have used it and still got HIV?”  “Most people who take PrEP correctly don’t get HIV, but a small number might ...

The Ghana AIDS Commission has unveiled plans to introduce an HIV preventive drug in 2026, marking a major step in the country rsquo;s fight against the virus, which saw more than 15,000 new infections ...

The governor, Senate president and House speaker signed 849 bills into law in 2025, more than 400 of which took effect Wednesday, Oct. 1. (Photo by Bryan P. Sears/Maryland Matters) How much time ...

This is the Global Health Checkup, five of the week’s most important stories on outbreaks, medicine, science, and survival from around the world. This week: a breakthrough on the price of a new HIV ...

The Smith County Jail continues to gain medical support through local entities, creating a safer environment for incarcerated individuals and staff members, despite fluctuating costs. While the jail ...

Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage – NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, ...

This is the first government shutdown since 2018. That shutdown, which stretched into early 2019, lasted for 35 days.

Drug pricing has been a national issue for decades. The proposed tariffs are intended to push more drug manufacturing to the United States, administration officials have said.

Lamivudine/dolutegravir is effective as first-line therapy for HIV infection, with low rates of treatment failure.